BlackRock’s RenovoRx RNXT Stock Holding History
Bought
Maintained
Sold
Other funds holding RNXT
ACM
NPT
KAS
ACA
BlackRock's RNXT Position: Q3 2024 in Review
BlackRock sold out of RenovoRx (RNXT) in Q3 2024, closing a stake of 9,162 shares — an estimated $10.4K sold.
BlackRock first reported a position in RNXT in Q1 2022 and held it in 5 quarters. The position peaked at $49K in Q4 2023. 13 funds tracked by Wall St. Rank hold RNXT as of Q3 2024.
- BlackRock reported no remaining RenovoRx position as of Q3 2024 after selling out during the quarter.
- BlackRock sold 9,162 RenovoRx shares in Q3 2024, an estimated $10.4K.
- BlackRock first reported a position in RenovoRx in Q1 2022 and held it in 5 quarters.
- BlackRock's RenovoRx position peaked at $49K in Q4 2023.
- 13 funds tracked by Wall St. Rank held RenovoRx as of Q3 2024.
Based on BlackRock's 13F filing for Q3 2024, filed 13 Nov 2024.